ClinicalTrials.gg
RecruitingNCT06941922Updated Jul 11, 2025

Testicular Evaluation of Azoospermia Using Micro-Ultrasound

An observational study in Azoospermia, sponsored by Paul Shin. Recruiting at 2 sites in 2 countries. Open to male participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-07-11.

Sponsored by Paul Shin · Observational

From the registry’s dates

  • Primary completion was expected by Oct 2025, 1 year ago, but the record still lists the study as recruiting.
  • Started May 2025; still recruiting 1 year 6 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
40
Ages
18 Years and older
Sex
Male
01

Study summary

The investigation is a small feasibility study to determine whether there are imaging features related to the seminiferous tubules in the testes under microultrasound. The results from this study will provide guidance on the design and power analysis of future studies in this area.

Read the detailed description

Currently available ultrasound (US) technology is approximately 12 MHz and offers enough resolution to determine the presence of a tumor or varicocele, but has no real predictive value in terms of imaging robust seminiferous tubules. MicroUS offers significantly higher resolution - down to 70 microns. The average width of a normal seminiferous tubule is 200-250 microns. (Amer 1837). The average width of an atrophic SCO tubule is 75 microns. This echotexture difference cannot be visualized by a conventional ultrasound scan but should, in theory, be detected by a higher resolution (higher MHz) microUS scan.

This is a feasibility study to image 40 azoospermic or healthy controls in order to determine whether microultrasound (microUS) images can visualize differences within the testes of these subjects which may be useful in diagnosing the cause of azoospermia and regional differences within the testes where sperm retrieval may be more effective.

Specifically, in men with obstructive azoospermia we expect to visualize normal seminiferous tubules while in men with non-obstructive azoospermia we expect to visualize both normal and atrophic seminiferous tubules.

The normal tubules in cases of obstructive azoospermia will act as a control by providing an example of normal imaging within a closely related population. Localization of normal tubules within the NOA (non-obstructive azoospermia) population may simplify the microTESE procedure by reducing the amount of dissection required. Additionally, the ability to predict the success of the procedure (i.e. presence of normal tubules) would improve risk/benefit decision-making for men considering it.

02

Conditions studied

  • Azoospermia

Keywords

  • azoospermia, infertility, microultrasound, microdissection
03

In context

Azoospermia

59 studies on the registry are indexed under Azoospermia; 17 are open to participants now.

This study's planned enrollment of 40 is below the median of 95 across 24 observational studies indexed under Azoospermia.

Browse Azoospermia studies →

Lead sponsor

This is the only study on the registry with Paul Shin as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Participants who meet inclusion and exclusion criteria and have been referred to the study infertility clinic.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Men with azoospermia confirmed based on semen analysis
  2. Post-vasectomy patients with verified azoospermia after the procedure
  3. Men pre-vasectomy with proven natural fertility or with normal semen analysis
  4. Males assigned at birth over the age of 18

Exclusion criteria

Exclusion criteria:

  1. History of prior microdissection of the testes
  2. History of hypogonadotropic hypogonadism
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
40 participants (estimated)
Patient registry
No

Groups and cohorts

  • Men with azoospermia confirmed based on semen analysis
  • Post-vasectomy patients with verified azoospermia after the procedure
  • Men pre-vasectomy with proven natural fertility or with normal semen analysis
06

What researchers measure

Primary outcomes

  1. The micro-ultrasound imaging procedure produces imaging features which correlate to the presence of sperm within the seminiferous tubules of the testes

    The investigation is a small feasibility study to determine whether there are imaging features related to the seminiferous tubules in the testes under microUS. The results from this study will provide guidance on the design and power analysis of future studies in this area.

    Time frame: From time of enrollment to end of scanning (45 minutes)

07

Study locations

2 of 2 sites recruiting
  • Shady Grove Fertility
    Rockville, Maryland 20850, United States
    Recruiting
    • Paul R Shin, MD · Contactpaul.shin@sgfertility.com · 202-295-2595
    • Paul R Shin, MD · Principal investigator
    • Cori Tanrikut, MD · Sub investigator
    • Russell Hayden, MD · Sub investigator
    • Jessica Marinaro, MD · Sub investigator
  • University of Alberta
    Edmonton, Alberta T6G 1Z1, Canada
    Recruiting
    • Philip V Bach, MD · Contactpbach@ualberta.ca · 780-407-5800
    • Adam Kinnaird, MD, PhD · Contactask@ualberta.ca · 780-407-5800
    • Adam Kinnaird, MD, PhD · Sub investigator
    • Philip V Bach, MD · Principal investigator
    • Matthew Mancuso, MD · Sub investigator
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 11, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06941922
Lead sponsor
Paul Shin
Collaborators
Exact Imaging
Responsible party
Paul Shin (Principal Study Investigator, Shady Grove Fertility Reproductive Science Center) — Sponsor-investigator
First posted
Apr 24, 2025
Start date
May 1, 2025
Primary completion
Oct 31, 2025 (estimated)
Completion
Dec 31, 2025 (estimated)
Last update
Jul 11, 2025

Study contacts

Paul R Shin, MD
Contact
paul.shin@sgfertility.com
202-296-2595
Cori Tanrikut, MD
Contact
cori.tanrikut@sgfertility.com
(202)296-2595
Paul R Shin, MD
principal investigator · Shady Grove Fertility

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion